NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.42% | 8.14% | -180.54% | 51.67% | 45.77% |
| Total Depreciation and Amortization | -29.43% | -8.54% | 0.61% | 0.31% | 5.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -152.27% | 1,848.21% | 829.07% | -2.87% | -88.58% |
| Change in Net Operating Assets | 1,781.86% | -85.98% | 1.83% | -122.19% | -210.48% |
| Cash from Operations | 26.08% | -2,268.45% | -1,597.98% | 42.79% | 38.00% |
| Capital Expenditure | 54.71% | -1,103.13% | -67.21% | 71.27% | -193.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 54.71% | -1,103.13% | -67.21% | 71.27% | -193.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.10% | 61.93% | -- | -100.00% | 446.51% |
| Repurchase of Common Stock | 8.57% | 43.23% | 68.14% | 71.43% | 92.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.89% | 100.00% | 95.40% | -95.94% | -1,172.97% |
| Cash from Financing | -95.81% | 148.61% | 129.02% | -97.37% | 427.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.26% | -507.53% | -823.79% | -818.89% | 924.77% |